Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:PIII On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePIIIP3 Health Partners$8.21-4.0%$8.82$7.00▼$36.50$58.96M0.9420,540 shs2,276 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePIIIP3 Health Partners-1.33%-4.11%+1.01%-13.21%-77.20%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationPIIIP3 Health Partners1.8486 of 5 stars3.34.00.00.00.60.80.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePIIIP3 Health Partners 2.50Moderate Buy$16.2597.93% UpsideCurrent Analyst Ratings BreakdownLatest PIII Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/21/2025PIIIP3 Health PartnersLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$50.00 ➝ $20.00(Data available from 5/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPIIIP3 Health Partners$1.50B0.04$3.54 per share2.32$0.45 per share18.24Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePIIIP3 Health Partners-$57.77M-$49.00N/AN/AN/A-6.95%-71.31%-11.93%5/14/2025 (Estimated)Latest PIII EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025PIIIP3 Health Partners-$5.00N/AN/AN/A$362.09 millionN/A3/27/2025Q4 2024PIIIP3 Health Partners-$8.50-$16.00-$7.50-$0.36$378.88 million$370.69 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthPIIIP3 Health PartnersN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioPIIIP3 Health Partners1.110.530.53Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipPIIIP3 Health Partners7.75%Insider OwnershipCompanyInsider OwnershipPIIIP3 Health Partners15.76%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionablePIIIP3 Health Partners5007.18 million294.74 millionNot OptionablePIII HeadlinesRecent News About These CompaniesP3 Health Partners (PIII) to Release Quarterly Earnings on WednesdayMay 9 at 8:34 AM | marketbeat.comShort Interest in P3 Health Partners Inc. (NASDAQ:PIII) Drops By 97.2%April 28, 2025 | marketbeat.comP3 Health Partners (NASDAQ:PIII) Price Target Cut to $20.00 by Analysts at Lake Street CapitalApril 23, 2025 | marketbeat.comP3 Health Partners price target lowered to $20 from $50 at Lake StreetApril 21, 2025 | markets.businessinsider.comP3 Health Partners (NASDAQ:PIII) Reaches New 52-Week Low - Time to Sell?April 17, 2025 | marketbeat.comP3 Health Partners (NASDAQ:PIII) Shares Gap Down - Should You Sell?April 16, 2025 | marketbeat.comP3 Health Partners (PIII) Stock Jumps 8.9%: Will It Continue to Soar?April 16, 2025 | zacks.comP3 Health Partners Earnings Estimates, EPS & Revenue | NASDAQ:PIII | BenzingaApril 15, 2025 | benzinga.comP3 Health Partners Earnings Estimates, EPS & Revenue | NASDAQ:PIII | BenzingaApril 15, 2025 | benzinga.comP3 Health Partners Inc trading halted, news pendingApril 12, 2025 | markets.businessinsider.comP3 Health Partners to Participate in the 24th Annual Needham Virtual Healthcare ConferenceApril 2, 2025 | businesswire.comP3 Health Partners (PIII) Gets a Hold from TD CowenMarch 29, 2025 | markets.businessinsider.comP3 Health Partners backs FY25 revenue view $1.35B-$1.5B, consensus $1.4BMarch 28, 2025 | markets.businessinsider.comWilliam Blair Sticks to Their Buy Rating for P3 Health Partners (PIII)March 28, 2025 | markets.businessinsider.comP3 Health Partners posts wider-than-expected Q4 loss, revenue miss; Shares fallMarch 27, 2025 | investing.comP3 Health Partners Inc. (PIII) Q4 2024 Earnings Conference Call TranscriptMarch 27, 2025 | seekingalpha.comP3 Health Partners Inc. (PIII) Reports Q4 Loss, Lags Revenue EstimatesMarch 27, 2025 | zacks.comP3 Health Partners Announces Fourth Quarter and Full Year 2024 ResultsMarch 27, 2025 | businesswire.comP3 Health Partners to Report Fourth Quarter and Full Year 2024 Financial Results on March 27March 13, 2025 | finance.yahoo.comP3 Health Partners (PIII) Could Find a Support Soon, Here's Why You Should Buy the Stock NowMarch 5, 2025 | zacks.comP3 Health Partners to Participate in the TD Cowen 45th Annual Health Care ConferenceFebruary 19, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePIII Company DescriptionsP3 Health Partners NASDAQ:PIII$8.21 -0.34 (-3.98%) As of 01:34 PM EasternP3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs Why Nearly 20 Analysts Raised Meta Price Targets Post-Earnings Strategists Say Hold: Stocks May Beat the 'Sell in May' Trend What the ExtraHop Deal Means for CrowdStrike DoorDash’s Uptrend Is Gaining Momentum in 2025 Why Flutter Entertainment May Be a Resilient Sports Betting Stock OXY Stock Rebound Begins Following Solid Earnings Beat Is Energy Transfer Undervalued or a Value Trap? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
